Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market Clinical Performance and Safety Evaluation of GamCath HighFlow Dolphin Protect Catheter

NCT05888376 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT05888376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05888376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market Clinical Performance and Safety Evaluation of GamCath HighFlow Dolphin Protect Catheter
Lead sponsor
Vantive Health LLC
Phase
Observational
Overall status
Completed
Start date
December 7, 2023
Completion date
April 30, 2024
Enrollment
76 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal failure, aki - acute kidney injury, ckd, esrd